Průběžná roční a bezpečnostní zpráva o průběhu klinického hodnocení Disulfiram Česká republika (Identifikační znak klinického hodnocení: sukls438883/2018)

Title in English Disulfiram Interim annual and safety report on the course of the clinical trial Czech Republic (Identification mark of the clinical trial: sukls438883 / 2018)


Year of publication 2021
MU Faculty or unit

Faculty of Medicine

Description "EFFECT OF DISULFIRAM AND COPPER TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER: a prospective, open-label, single-arm phase II study." The study is accompanied by a sub-study that will obtain further data and better assess the antitumor efficacy of disulfiram and copper treatment. This substudy aims to analyze other biochemical blood parameters related to determining disulfiram levels and their concentration in the blood.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info